EPISODE · Dec 19, 2025 · 2 MIN
UK-US Trade Tensions Rise: Pharmaceutical Deal Shaky, Tech Prosperity Suspended, Tariff Uncertainty Looms
from United Kingdom Tariff News and Tracker · host Inception Point AI
Welcome to United Kingdom Tariff News and Tracker, where we break down the latest twists in US-UK trade under President Trump. Tensions are rising over the so-called milestone UK-US pharmaceuticals deal struck in early December. According to BM Magazine, this agreement promises zero tariffs on UK pharmaceuticals exported to the US for three years, but it's built on shaky ground with no detailed legal text yet—just high-level press releases. The UK government hails it as securing tariff-free access, while the US statement, as reported by the National Law Review, emphasizes higher prices for medicines supplied to the NHS, potentially up by 25%. Critics like trade expert David Henig warn the UK is offering concrete commitments for mere political assurances from an unpredictable administration. Adding to the uncertainty, the Trump team has suspended the £31 billion tech prosperity deal, citing slow UK progress on lowering trade barriers, per American Action Forum's Shipment newsletter. This follows the May Economic Prosperity Deal, touted as historic by PM Keir Starmer, which still lacks US approval for concessions to British farmers, including beef export quotas. The National Farmers' Union urges confirmation before year's end to avoid leverage in future talks. On a brighter note, the UK dodged steeper hits: avoiding 50% tariffs on steel and aluminum imposed elsewhere, and securing a reduced 10% tariff on car exports within quotas, as noted by government officials in BM Magazine. Yet MPs like Liam Byrne and Layla Moran call these pacts fragile, with one minister privately dubbing them built on sand amid Trump's volatility. As US tariff revenue soars—$216.7 billion in fiscal 2025, up 146% from last year per American Action Forum—UK exporters face ongoing risks. Talks resume in January, but legal certainty remains elusive. Thanks for tuning in, listeners—subscribe now for weekly updates on tariffs impacting Britain. This has been a Quiet Please production, for more check out quietplease.ai. For more check out https://www.quietperiodplease.com/ Avoid ths tariff fee's and check out these deals https://amzn.to/4iaM94Q This content was created in partnership and with the help of Artificial Intelligence AI.
What this episode covers
Welcome to United Kingdom Tariff News and Tracker, where we break down the latest twists in US-UK trade under President Trump. Tensions are rising over the so-called milestone UK-US pharmaceuticals deal struck in early December. According to BM Magazine, this agreement promises zero tariffs on UK pharmaceuticals exported to the US for three years, but it's built on shaky ground with no detailed legal text yet—just high-level press releases. The UK government hails it as securing tariff-free access, while the US statement, as reported by the National Law Review, emphasizes higher prices for medicines supplied to the NHS, potentially up by 25%. Critics like trade expert David Henig warn the UK is offering concrete commitments for mere political assurances from an unpredictable administration. Adding to the uncertainty, the Trump team has suspended the £31 billion tech prosperity deal, citing slow UK progress on lowering trade barriers, per American Action Forum's Shipment newsletter. This follows the May Economic Prosperity Deal, touted as historic by PM Keir Starmer, which still lacks US approval for concessions to British farmers, including beef export quotas. The National Farmers' Union urges confirmation before year's end to avoid leverage in future talks. On a brighter note, the UK dodged steeper hits: avoiding 50% tariffs on steel and aluminum imposed elsewhere, and securing a reduced 10% tariff on car exports within quotas, as noted by government officials in BM Magazine. Yet MPs like Liam Byrne and Layla Moran call these pacts fragile, with one minister privately dubbing them built on sand amid Trump's volatility. As US tariff revenue soars—$216.7 billion in fiscal 2025, up 146% from last year per American Action Forum—UK exporters face ongoing risks. Talks resume in January, but legal certainty remains elusive. Thanks for tuning in, listeners—subscribe now for weekly updates on tariffs impacting Britain. This has been a Quiet Please production, for more check out quietplease.ai. For more check out https://www.quietperiodplease.com/ Avoid ths tariff fee's and check out these deals https://amzn.to/4iaM94Q This content was created in partnership and with the help of Artificial Intelligence AI.
NOW PLAYING
UK-US Trade Tensions Rise: Pharmaceutical Deal Shaky, Tech Prosperity Suspended, Tariff Uncertainty Looms
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m